Crux Biolabs Provides Luminex Australia bead-based assays are fully quantifiable multiplex immunoassays that have been used for many years in many peer-reviewed publications.
todays bird
Keni
let's talk about Bridgerton tea, my ask is open
🪼

Product Placement
tumblr dot com

Kiana Khansmith
RMH
Xuebing Du

Andulka

izzy's playlists!

ellievsbear

pixel skylines
No title available
Peter Solarz
Show & Tell

#extradirty
KIROKAZE
I'd rather be in outer space 🛸
he wasn't even looking at me and he found me
seen from Germany

seen from Belarus
seen from United States

seen from Türkiye
seen from Bulgaria

seen from Malaysia
seen from Poland

seen from Uruguay
seen from France
seen from United States

seen from Malaysia
seen from United States
seen from United States
seen from United States
seen from United States
seen from United Kingdom

seen from United States

seen from Uruguay
seen from United States
seen from Australia
@cruxbiolabs
Crux Biolabs Provides Luminex Australia bead-based assays are fully quantifiable multiplex immunoassays that have been used for many years in many peer-reviewed publications.
Maximizing Scientific Research and Innovation: A Closer Look at Crux Biolabs' Utilization of Luminex Technology
Luminex is a multiplex assay technology that enables the simultaneous detection and quantification of many analytes in a single sample. This method reduces the time, expense, and volume of reagents needed for conventional ELISA assays while yet offering a high level of sensitivity and specificity and allowing laboratories researchers to analyze many analytes in a single assay.
In the fields of clinical diagnostics, life science research, and drug development, Luminex technology has a wide variety of uses.
One of the many laboratories utilizing Luminex technology is Crux Biolabs, a privately owned research facility located in Bayswater, Australia. In this blog post, we will explore Luminex Australia's perspective on Crux Biolabs, including its capabilities, achievements, and contributions to the scientific community.
Overview of Crux Biolabs: Crux Biolabs is a contract research organization (CRO) specializing in preclinical and clinical studies, in vitro diagnostics (IVD), and bioanalytical services. The lab's focus is on immunoassays, cellular assays, and molecular biology, with a team of experienced scientists using cutting-edge technology to provide high-quality data and analysis. Crux Biolabs offers a range of services, including assay development, sample analysis, and biomarker discovery, to support drug development, clinical trials, and academic research.
Luminex Technology at Crux Biolabs: Luminex technology has been an integral part of Crux Biolabs' services since its establishment. The lab uses Luminex multiplex immunoassays to measure multiple analytes in a single sample, reducing the time, cost, and volume of reagents required for traditional ELISA assays. Luminex technology has also enabled Crux Biolabs to expand its capabilities to include cell-based assays, nucleic acid detection, and protein profiling, providing a more comprehensive analysis of biological samples.
Contributions to the Scientific Community: Crux Biolabs' expertise and use of Luminex technology have resulted in several scientific publications and presentations, including studies on cancer immunotherapy, infectious diseases, and drug development. The lab has also collaborated with academic and industry partners to develop new assays and biomarkers, contributing to the advancement of medical research and diagnostics.
Conclusion: Crux Biolabs is a premier research laboratory in Australia, providing high-quality services and expertise in immunoassays, cellular assays, and molecular biology. Its partnership with Luminex Australia has enabled the lab to offer innovative and comprehensive solutions for drug development, clinical trials, and academic research. Luminex technology has played a crucial role in Crux Biolabs' success, allowing for multiplex analysis and expanding the lab's capabilities. As a result, Crux Biolabs has made significant contributions to the scientific community, furthering the understanding and treatment of various diseases.
Flow Cytometry enables the detection and quantification markers on immune cells. Crux Biolab’s flow cytometry services are performed on CytoFLEX Platform instruments with up to 21 colours.
Crux Biolabs
Crux Biolabs operates a laboratory for vaccines, immunotherapies, immuno-oncology, and infectious diseases. The firm conducts specialist immunology contract research services for pre-clinical and clinical studies, as well as academic and biotech R&D, through its NATA accredited facility in Melbourne. It was founded in 2011 and is based in Bayswater, Victoria.
Crux Biolabs operates a laboratory for vaccines, immunotherapies, immuno-oncology, and infectious diseases. The firm conducts specialist immunology contract research services for pre-clinical and clinical studies, as well as academic and biotech R&D, through its NATA accredited facility in Melbourne. It was founded in 2011 and is based in Bayswater, Victoria Australia.